| more general categories |
information about this item |
|
| 03. Biological Effects of Specific Chemicals |
 |
 |
|
03. Biological Effects of Specific Chemicals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
saxagliptin hydrate [CHEBI:71271] (1) |
|
 |
| 05. Industrial Uses |
 |
 |
|
05. Industrial Uses |
|
|
|
|
|
|
|
|
|
|
|
saxagliptin hydrate [CHEBI:71271] (1) |
|
 |
| 08. Chemical Category |
 |
 |
|
08. Chemical Category |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
saxagliptin hydrate [CHEBI:71271] (1) |
|
 |
| ChEBI Compound Accession Identifier: |
[CHEBI:71271] |
| ChEBI Compound Description: |
A hydrate that is the monohydrate form of anhydrous saxagliptin. Used for the treatment of Type II diabetes. |
| ChEBI Compound Identification Number: |
71271 |
| ChEBI InChI Value: |
"InChI=1S/C18H25N3O2.H2O/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17;/h10-15,23H,1-7,9,20H2;1H2/t10?,11?,12-,13+,14+,15-,17?,18?;/m1./s1" |
| ChEBI InChIKey Value: |
AFNTWHMDBNQQPX-NHKADLRUSA-N |
| ChEBI Compound Name: |
saxagliptin hydrate |
| ChEBI SMILES Value: |
O.[H][C@]12C[C@@H](C#N)N(C(=O)[C@@H](N)C34CC5CC(CC(O)(C5)C3)C4)[C@@]1([H])C2 |
| ChEBI Substance ID: |
162169184 |
| ChEBI URL: |
ChEBI:71271 |
| ChemSpider ID: |
28530658 |
| Ontomatica Chemical Accession Key (OnChAKey): |
AFNTWHMDBNQQPX_NHKADLRUSA_N_000_000000 |
| PubChem Compound ID: |
53297473 |